Administrative correction to covid 19 testing /molecular analyzer/reagents - high volume output analyzer without the need to aliquot - add products to attachment a
Ended Awarded Last action
- Contract number
- 36C25525N0001
- Awardee
-
Abbott Molecular Inc. UEI NK5QDVJBHMN7 Part of Abbott Laboratories
- Awarding agency
-
Veterans Integrated Service Network 15
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- -$939,336
Award facts
- Contract value 0% obligated
- $373,277.97 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Rosemont, IL 60018, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$227,857 | |
| Other Administrative Action | -$711,479 | |
| Other Administrative Action | $0 | |
| Original award | $1,312,614 |
About this award
Abbott Molecular Inc., a subsidiary of Abbott Laboratories, received an administrative correction call order valued at $373,277.97 under a Blanket Purchase Agreement with Veterans Integrated Service Network 15, a division of the Department of Veterans Affairs. This firm fixed-price delivery order, awarded on October 15, 2024, with a completion date of October 14, 2025, adds products to the contract's attachment and procures COVID-19 testing molecular analyzers and reagents designed for high-volume output without requiring sample aliquoting. The award is issued under the General Services Administration's In-Vitro Diagnostics, Reagents, Test (FSS-65-VII) schedule, which streamlines federal procurement of diagnostic testing supplies and equipment across the VA healthcare system.
Abbott Molecular has established itself as a critical supplier to the VA through multiple BPAs across various Veterans Integrated Service Networks, with existing agreements totaling over $12 million for Alinity M diagnostic equipment and consumables. This contract does not carry a small business set-aside designation, consistent with Abbott's status as a large, established medical technology corporation. The procurement supports the VA's ongoing diagnostic testing infrastructure and pandemic response capabilities by ensuring consistent access to advanced molecular testing platforms and associated reagents for infectious disease screening across the VISN 15 healthcare network.
Quick answers
Who was awarded contract 36C25525N0001?
36C25525N0001 was awarded to Abbott Molecular Inc. by Veterans Integrated Service Network 15 (Veterans Health Administration) on October 15, 2024.
How much is contract 36C25525N0001 worth?
The government has obligated -$939,336 on 36C25525N0001. Its current value, with exercised options, is $373,278.
Is contract 36C25525N0001 an order under another contract?
Yes. 36C25525N0001 is a BPA call under V797D40222-36C25521A0001, a blanket purchase agreement, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract 36C25525N0001 competed?
The extent of competition for 36C25525N0001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award